Krystyna Tatarkiewicz

Summary

Affiliation: Amylin Pharmaceuticals
Country: USA

Publications

  1. pmc No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks
    K Tatarkiewicz
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Diabetes Obes Metab 15:417-26. 2013
  2. pmc Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
    Krystyna Tatarkiewicz
    Amylin Pharmaceuticals, San Diego, CA, USA
    Am J Physiol Endocrinol Metab 299:E1076-86. 2010

Detail Information

Publications2

  1. pmc No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks
    K Tatarkiewicz
    Amylin Pharmaceuticals, LLC, San Diego, CA 92121, USA
    Diabetes Obes Metab 15:417-26. 2013
    ..This study evaluated the long-term effects of the GLP-1RA exenatide on pancreatic exocrine structure and function in the Zucker diabetic fatty (ZDF) rat model of type 2 diabetes...
  2. pmc Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
    Krystyna Tatarkiewicz
    Amylin Pharmaceuticals, San Diego, CA, USA
    Am J Physiol Endocrinol Metab 299:E1076-86. 2010
    ..In conclusion, exenatide did not modify plasma amylase and lipase concentrations in rodents without pancreatitis and improved chemically induced pancreatitis in normal and diabetic rodents...